How long should you stay on Suboxone?

Why the “Short Course” Idea Falls Apart

A lot of people start Suboxone thinking of it like a round of antibiotics. You take it for a set time, the problem clears up, and you stop. That model fits an infection. It does not fit opioid use disorder (OUD), which behaves more like a long-term health condition with a real chance of coming back.

Opioids change how the brain handles reward, stress and motivation. Those changes do not reset the day withdrawal ends. Cravings can return months or years later, often triggered by stress, pain, grief, old places or old friends. Buprenorphine, the main ingredient in Suboxone, keeps opioid receptors steadily occupied so those triggers land with less force. If you want a refresher on that mechanism, our guide to what Suboxone does to your body covers it in plain terms.

A comparison that helps some people: nobody expects a person with high blood pressure to stop their medicine once their numbers look good. The good numbers are the medicine working. Feeling stable on Suboxone is often the same story. The comparison has limits, of course. OUD carries stigma that blood pressure does not, and stopping Suboxone can be done safely for some people. But the core idea holds: doing well on treatment is not, by itself, proof that you no longer need it.

Where the short-course belief comes from

Part of it is history. For decades, many programs treated opioid addiction mainly with detox, a short period of managed withdrawal followed by abstinence. Some insurance plans and treatment programs also set time limits that had more to do with cost than medicine. On top of that, many people feel pressure from family, employers, or recovery groups to prove they are “really” clean by stopping medication. Our page on Suboxone myths vs facts tackles the most common of these beliefs one by one.

How Long to Stay on Suboxone: What the Evidence Shows

The most useful study on this question comes from a team led by Arthur Robin Williams, published in the American Journal of Psychiatry in 2020. Researchers used insurance claims data (MarketScan Medicaid, 2013 to 2017) to follow 8,996 adults who had been on buprenorphine continuously and then stopped.

The team grouped people by how long they had been in treatment before stopping: 6 to 9 months, 9 to 12 months, 12 to 15 months, or 15 to 18 months. Then they looked at what happened in the six months after the medicine ended.

Time on buprenorphine before stopping	Medically treated overdose in the 6 months after stopping	How this group compared
6 to 9 months	About 5%	Reference group for comparisons
9 to 12 months	About 5%	Overdose rate about the same
12 to 15 months	About 5%	Overdose rate about the same
15 to 18 months	About 5%	Somewhat lower odds of ER visits (OR 0.75), hospital stays (OR 0.79) and opioid prescription fills (OR 0.67) than the 6 to 9 month group

Across all groups, between 42.1% and 49.9% of people had an emergency department visit during those six months. That is a lot of emergencies for a group of people who had been stable enough to stay on medicine for at least half a year.

What the study shows

• Stopping carries real risk at every point studied. Roughly 1 in 20 people had an overdose serious enough to need medical care within six months, whether they had been treated for 6 months or 18.
• Longer treatment helped, but only modestly. People who stayed 15 to 18 months had somewhat fewer ER visits, hospital stays and opioid prescriptions after stopping. Their overdose rate was not clearly lower.
• Eighteen months is not a finish line. The study offers no evidence that there is a “safe” point at which stopping becomes low risk.

What the study does not show

• It cannot tell us about your situation. Claims data show prescriptions and hospital visits, not why people stopped. Some may have stopped because of cost, a move, a lost insurance plan or a fight with a clinic, not because they felt ready.
• It did not compare planned tapers with sudden stops. A slow, supported taper that you chose may look very different from losing access overnight.
• It did not follow people past six months after stopping, and it did not study people treated for many years.
• It is observational. It shows patterns, not cause and effect. People who stay longer may differ in other ways too.

Even with those limits, the main message is hard to ignore. Choosing an arbitrary stop date, such as “one year and done,” is not backed by evidence. If anything, the data push toward staying longer and stopping only with a plan.

The bigger picture on staying in treatment

Other research points the same way. A 2019 report from the National Academies of Sciences, Engineering, and Medicine, titled Medications for Opioid Use Disorder Save Lives, reviewed the evidence and concluded that medications such as buprenorphine and methadone are effective and lifesaving. Observational studies have linked being on these medicines with much lower risk of dying from overdose while treatment continues. The World Health Organization also lists both buprenorphine and methadone on its Model List of Essential Medicines.

What Treatment Guidelines Say About Suboxone Treatment Duration

ASAM’s National Practice Guideline (2020 focused update) is one of the main documents US clinicians use for OUD care. On the question of Suboxone treatment duration, it does not set a time limit. It treats buprenorphine as something that can continue long term, even indefinitely, and it says the decision to stop should be centered on the patient.

In practice, that means a few things:

• Your prescriber should not push you off on a schedule. A good program does not discharge people simply because a set number of months has passed.
• You are allowed to want to stop. Patient-centered care cuts both ways. If you are stable and want to try a taper, that goal deserves a real conversation, not a lecture.
• Progress is measured by how you are living, not by how low your dose is or how many months you have been on it.

Since early 2023, the federal “X-waiver” rule is gone. Any clinician with a Schedule III DEA registration can prescribe buprenorphine for OUD. That change matters for long-term care, because it means more primary care doctors, nurse practitioners and physician assistants can keep you on maintenance treatment close to home.

Is It Okay to Be on Suboxone Long Term?

For many people, yes. When patients ask how long to stay on Suboxone, the safety record of long-term use is usually the first worry. Suboxone long term is a common and accepted way to manage OUD. That does not mean it is free of side effects, and it does not mean you can skip checkups. Here is what is known about staying on it for years, and what good monitoring looks like.

Physical dependence is expected

Your body adapts to buprenorphine, so stopping suddenly causes withdrawal. That is physical dependence, and it also happens with many blood pressure, seizure and mood medicines. It is not the same as addiction, which involves compulsive use despite harm and loss of control. Someone taking a steady dose as prescribed, working and keeping up with life, is dependent but not using compulsively.

Side effects to keep an eye on

Common side effects listed on the label include headache, nausea, constipation, sweating, trouble sleeping and swelling in the hands or feet. Many fade after the first weeks. Constipation and sweating are the ones people most often report sticking around.

More serious risks on the label include:

• Breathing problems when combined with sedatives. Buprenorphine has a “ceiling effect” on breathing when used alone, but that protection does not hold up when it is mixed with benzodiazepines, alcohol or other sedating drugs. See our page on Suboxone and Xanax for why that combination worries prescribers.
• Liver problems. The label recommends liver tests, usually before starting and from time to time during treatment.
• Adrenal problems, low blood pressure on standing, and allergic reactions, which are uncommon but worth knowing about.
• Serotonin syndrome if combined with certain antidepressants or other serotonergic drugs. Tell every prescriber what you take.
• Sleep apnea, which can be worse with opioid-type medicines.

Dental health

In January 2022, the FDA warned about dental problems such as cavities, infections and tooth loss linked to buprenorphine medicines that dissolve in the mouth, including Suboxone film. The FDA also said the benefits clearly outweigh the risks. For long-term users, a few habits help: after the film fully dissolves, take a large sip of water, swish gently and swallow; wait at least an hour before brushing; and see a dentist regularly. More tips are in our article on Suboxone and tooth decay.

A simple monitoring routine

People on Suboxone maintenance for years usually settle into a routine like this, set by their clinic:

• Regular visits, which often spread out over time once you are stable
• Liver blood tests at intervals your prescriber chooses
• Dental checkups, ideally every six months or as your dentist advises
• A yearly review of every medicine and supplement you take
• Check-ins on sleep, mood, pain and alcohol use
• A current naloxone kit at home, even when things are going well

Signs You May Be Ready to Talk About Stopping

Some people do reach a point where tapering makes sense, and thinking through how long to stay on Suboxone is part of that. Clinicians tend to look at your whole life, not just your time on medicine. These questions can help you take stock before you raise it with your prescriber. There is no score. A string of honest “no” answers is simply useful information.

1. Have I gone a long stretch with no opioid use and no close calls?
2. Are my cravings rare and easy to manage, even under stress?
3. Is my housing stable and safe?
4. Do I have people I can call at 2 a.m. if things go sideways?
5. Do I have coping skills that I actually use, such as counseling, a peer group, exercise or a sponsor?
6. Is my life relatively calm right now, without a major move, breakup, job loss or loss of a loved one on the horizon?
7. Is my mental health, including anxiety, depression and sleep, in decent shape?
8. Do I want to stop for my own reasons, not because someone else is pushing me?
9. Am I willing to slow down, pause, or go back up if the taper gets rough?
10. Do I know that my tolerance will drop, and do I have naloxone and a safety plan?

If several of these feel shaky, it may simply not be the right season. That is not failure. Stress, poor sleep and anxiety all make a taper harder; our guides on the effects of stress on the body and improving sleep may help you shore those up first.

Why People Want to Stop, and Options Besides Stopping

When to stop Suboxone is often less about recovery and more about the hassle or the stigma around it. Those reasons are real, and they can shape how long to stay on Suboxone more than any study does. But many of them have fixes that do not involve giving up a medicine that is working. Here are common reasons, matched with alternatives worth raising first.

Reason for wanting to stop	Options to discuss before stopping
Cost or insurance trouble	Ask about generic buprenorphine/naloxone, Medicaid eligibility, prior authorization help, or a clinic with sliding-scale fees
Stigma or judgment from others	Counseling or peer groups that support medication; sharing reliable information with family; deciding who really needs to know
Side effects	Dose adjustment, timing changes, treating constipation or sweating directly, dental care, or switching formulation
Daily dosing feels like a reminder of addiction	A monthly or weekly extended-release injection such as Sublocade or Brixadi
Frequent visits or travel	Telehealth follow-ups, a closer provider, or a longer gap between visits once stable
Planning a pregnancy	Staying on treatment is usually advised; talk with your prescriber and OB early
Feeling “flat” or foggy	Review other medicines, sleep and mood; a modest dose change may help
Unhappy with your clinic	Changing providers instead of stopping treatment

Switching to an injection

Some people mainly dislike the daily routine. An extended-release buprenorphine injection can take that off your plate. Sublocade is given monthly by a healthcare provider, and Brixadi comes in weekly and monthly versions. In 2025, the FDA approved label changes for Sublocade that allow a faster start and more injection sites. Injections also avoid the dental issue tied to dissolving forms. Our comparison of Sublocade vs Suboxone lays out the trade-offs.

Changing medicines or providers

Buprenorphine is not the only option. Methadone and naltrexone are also FDA-approved for OUD, and each fits different people. Our pages on Suboxone vs methadone, methadone vs buprenorphine, and naltrexone vs Suboxone explain the differences. Naltrexone requires being fully off opioids first, which is a big step, so it is a conversation for later in recovery, not a shortcut.

If your frustration is really with one clinic, a new provider may fix it. Our guide to finding a Suboxone provider covers what to look for, and the SAMHSA treatment finder lists options near you.

A note on pregnancy

Many people think they need to stop before having a baby. Major groups, including ACOG and SAMHSA, generally recommend staying on medication for OUD during pregnancy rather than going through withdrawal, because withdrawal is tied to relapse and overdose. A large 2024 study in JAMA found that buprenorphine with naloxone was a reasonable option in pregnancy alongside buprenorphine alone. If you are planning a pregnancy, tell your prescriber early so you can plan together.

If You Decide to Stop: What a Good Plan Includes

Deciding how long to stay on Suboxone is your call, made with your care team. If you and your prescriber agree it is time, the way you stop matters as much as when. A good plan has several pieces:

• A slow, gradual taper. Dose cuts happen over weeks to months, at a pace you can handle. Your prescriber sets the specifics.
• You stay in the driver’s seat. The taper should be voluntary and patient-led. You can ask to pause, slow down or go back up, and that is a normal part of the process.
• Support stays in place. Counseling, peer support or a recovery group should continue during and after the taper, not end with the last dose.
• An overdose safety plan. Your tolerance drops as your dose drops. A dose of opioids you could once handle can become deadly, especially with fentanyl in the drug supply. Keep naloxone at home and make sure the people around you know how to use it. Nasal naloxone is sold over the counter.
• A plan for symptoms. Your prescriber can talk with you about sleep, aches, anxiety and other withdrawal symptoms, and about medicines that may ease them.
• A return path. Agree in advance on what will happen if cravings return. Restarting buprenorphine is not a defeat; it is a sign the plan is working the way it should.

Our step-by-step guide to tapering off Suboxone walks through each phase of a taper, what withdrawal from buprenorphine tends to feel like, and how to stay safe in the months afterward.

Frequently Asked Questions

How long should you take Suboxone?

There is no set rule for how long to stay on Suboxone. ASAM guidance puts no time limit on buprenorphine treatment, and many people take it for years. The best length is the one that keeps you stable, and any decision to stop should be planned with your prescriber.

Is it okay to be on Suboxone forever?

For some people, staying on Suboxone indefinitely is a reasonable and safe choice. Guidelines allow long-term treatment, and it is linked with a lower risk of overdose death while you are on it. You will still need regular checkups, including liver tests and dental visits.

Does staying on Suboxone longer make it safer to stop later?

Somewhat, but not by much. In a 2020 study of nearly 9,000 adults, people who stopped after 15 to 18 months had fewer ER visits and hospital stays than those who stopped after 6 to 9 months. About 5% in every group still had a medically treated overdose within six months of stopping.

What is the average length of buprenorphine treatment?

Many people stop within the first months, often because of cost, access or stigma rather than readiness. The research suggests that staying longer, and stopping only with a plan, leads to better outcomes. Averages also say little about what is right for you.

When is the right time to stop Suboxone?

The right time is when you want to stop for your own reasons and your life is stable, with support, low stress and a plan in place. Your prescriber can help you weigh those factors. Stopping during a crisis or under pressure from others raises the risk of relapse.

Can my doctor make me stop Suboxone after a certain time?

Guidelines do not support stopping treatment just because a set number of months has passed. If a clinic has a time limit you disagree with, ask why and consider getting a second opinion. You can also look for another provider who offers long-term maintenance.

What happens to my tolerance if I stop Suboxone?

Your tolerance to opioids drops after you stop, sometimes within days. That means a dose you once used could cause an overdose, especially with fentanyl in the drug supply. Keep naloxone on hand and make sure people close to you know how to use it.

Is Suboxone maintenance real recovery?

Yes. Recovery is about health, function and quality of life, and taking a prescribed medicine that supports those goals is part of recovery, not a detour from it. Major health agencies describe medications for OUD as effective treatment, not a swap of one addiction for another.

The Takeaway on How Long to Stay on Suboxone

When it comes to how long to stay on Suboxone, there is no finish line that research or guidelines agree on, and that is good news. It means you do not have to race the calendar. The best evidence shows that stopping carries real risk even after a year and a half, and that staying longer helps a little. If you feel pulled to stop, look at your reasons, check whether a dose change, an injection or a new provider would solve the real problem, and if you still want to taper, do it slowly with support and naloxone close by.

This article is for education only and is not medical advice. Do not start, stop or change any medicine without talking to your prescriber. Suboxone and other buprenorphine products are controlled substances and should be used only with a valid prescription. If you think someone is overdosing, call 911 right away. For free, confidential treatment referrals 24/7, call the SAMHSA National Helpline at 1-800-662-4357.

Sources

• Williams AR, et al. Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder. American Journal of Psychiatry, 2020. psychiatryonline.org
• National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives (2019).
• American Society of Addiction Medicine. National Practice Guideline for the Treatment of Opioid Use Disorder, 2020 Focused Update.
• U.S. Food and Drug Administration. FDA warns about dental problems with buprenorphine medicines dissolved in the mouth (January 2022).
• Indivior. FDA approval of label changes for Sublocade injection (2025).
• Straub L, et al. Buprenorphine-naloxone vs buprenorphine alone in pregnancy. JAMA 2024;332(10):805-816.
• SAMHSA. Find treatment and National Helpline.